Bassil
Bassil Akra, Munich DE
Patent application number | Description | Published |
---|---|---|
20120322047 | Apparatus And Method For Cell Exploitation - The present invention relates to an apparatus ( | 12-20-2012 |
Bassil Akra, Olching DE
Patent application number | Description | Published |
---|---|---|
20130344531 | METHOD OF EXAMINING TISSUE GROWTH AND CONDITIONING OF CELLS ON A SCAFFOLD AND A PERFUSION BIOREACTOR - Disclosed herein is a method of examining tissue growth and/or conditioning and/or adhesion properties of cells on a synthetic and/or natural scaffold ( | 12-26-2013 |
20140038258 | BIOREACTOR WITH MECHANICAL AND ELECTRICAL STIMULATION MEANS - Disclosed herein is a bioreactor for creating and/or conditioning biological tissues, in particular cardiovascular patches. This bioreactor supports additionally cellular differentiation under controlled conditions. The bioreactor comprises a housing having a first section ( | 02-06-2014 |
Bassil Akra, München DE
Patent application number | Description | Published |
---|---|---|
20130109007 | Bioreactor and Method for Creating and/or Conditioning Biological Tissues | 05-02-2013 |
Bassil Dahiyat, Altadena, CA US
Patent application number | Description | Published |
---|---|---|
20130202599 | NOVEL IMMUNOGLOBULINS INSERTIONS, DELETIONS, AND SUBSTITUTIONS - An Fc variant of a parent Fc polypeptide, wherein said Fc variant exhibits altered binding to one or more FcγRs, wherein said Fc variant comprises at least one amino acid insertion in the Fc region of said parent Fc polypeptide. | 08-08-2013 |
20150099863 | Fc VARIANTS WITH ALTERED BINDING TO FcRn - The present application relates to a variant Fc region comprising at least one modification relative to a wild-type human Fc region, where the modification selected from the group consisting of 434S, 252Y/428L, 252Y/434S, and 428L/434S, and the numbering is according to the EU index. | 04-09-2015 |
20150152183 | Fc VARIANTS WITH ALTERED BINDING TO FcRn - The present application relates to optimized IgG immunoglobulin variants, engineering methods for their generation, and their application, particularly for therapeutic purposes. | 06-04-2015 |
20150191533 | Fc VARIANTS WITH ALTERED BINDING TO FcRn - The present application relates to a variant Fc region comprising at least one modification relative to a wild-type human Fc region, where the modification selected from the group consisting of 434S, 252Y/428L, 252Y/434S, and 428L/434S, and the numbering is according to the EU index. | 07-09-2015 |
Bassil Dahiyat, Los Angeles, CA US
Patent application number | Description | Published |
---|---|---|
20150071948 | NOVEL IMMUNOGLOBULIN VARIANTS - The present invention relates to Fc variants with optimized Fc ligand binding properties, methods for their generation, Fc polypeptides comprising Fc variants with optimized Fc ligand binding properties, and methods for using same. | 03-12-2015 |
Bassil Dahiyat, Monrovia, CA US
Patent application number | Description | Published |
---|---|---|
20160068588 | ANTIBODIES WITH MODIFIED ISOELECTRIC POINTS AND IMMUNOFILTERING - The invention relates generally to compositions and methods for altering the isoelectric point of an antibody, and in some cases, resulting in improved plasma pharmacokinetics, e.g. increased serum half-life in vivo. | 03-10-2016 |